Phase I trial of EpCAM-targeting immunotoxin MOC31PE, alone and in combination with cyclosporin
出版年份 2015 全文链接
标题
Phase I trial of EpCAM-targeting immunotoxin MOC31PE, alone and in combination with cyclosporin
作者
关键词
-
出版物
BRITISH JOURNAL OF CANCER
Volume 113, Issue 11, Pages 1548-1555
出版商
Springer Nature
发表日期
2015-11-11
DOI
10.1038/bjc.2015.380
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Advances in Anticancer Immunotoxin Therapy
- (2015) C. Alewine et al. ONCOLOGIST
- Micrometastatic cancer cells in lymph nodes, bone marrow, and blood: Clinical significance and biologic implications
- (2014) Stanley P.L. Leong et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Immune Escape and Survival Mechanisms in Circulating Tumor Cells of Colorectal Cancer
- (2014) Gunnar Steinert et al. CANCER RESEARCH
- The MOC31PE immunotoxin reduces cell migration and induces gene expression and cell death in ovarian cancer cells
- (2014) Merete Wiiger et al. Journal of Ovarian Research
- EpCAM: Structure and function in health and disease
- (2013) Ulrike Schnell et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Clinical significance of disseminated tumour cells in non-small cell lung cancer
- (2013) A K Rud et al. BRITISH JOURNAL OF CANCER
- Immunotoxin targeting EpCAM effectively inhibits peritoneal tumor growth in experimental models of mucinous peritoneal surface malignancies
- (2013) Kjersti Flatmark et al. INTERNATIONAL JOURNAL OF CANCER
- Outside Slide Review in Gynecologic Oncology
- (2013) Ramez N. Eskander et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Immunotoxins: The Role of the Toxin
- (2013) Antonella Antignani et al. Toxins
- Disseminated tumour cells as a prognostic biomarker in colorectal cancer
- (2011) K Flatmark et al. BRITISH JOURNAL OF CANCER
- Clinical Implications of Pathophysiological and Demographic Covariates on the Population Pharmacokinetics of Trastuzumab Emtansine, a HER2-Targeted Antibody-Drug Conjugate, in Patients With HER2-Positive Metastatic Breast Cancer
- (2011) Manish Gupta et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Synergistic Anticancer Effects of the 9.2.27PE Immunotoxin and ABT-737 in Melanoma
- (2011) Karianne Risberg et al. PLoS One
- EpCAM in carcinogenesis: the good, the bad or the ugly
- (2010) B. T. F. van der Gun et al. CARCINOGENESIS
- Anti-Melanoma Activity of the 9.2.27PE Immunotoxin in Dacarbazine Resistant Cells
- (2010) Karianne Risberg et al. JOURNAL OF IMMUNOTHERAPY
- Synergistic anti-cancer effects of immunotoxin and cyclosporin in vitro and in vivo
- (2009) Y Andersson et al. BRITISH JOURNAL OF CANCER
- Immunomagnetic detection of micrometastatic cells in bone marrow in uveal melanoma patients
- (2008) Nils Eide et al. ACTA OPHTHALMOLOGICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started